Federal Court upholds validity of one pneumococcal vaccine patent, but holds two other patents invalid

Published date18 May 2021
Subject MatterPatents,Vaccinations,Patent Validity,Anticipation,Pharmaceutical Industry,Obviousness-Type Double Patenting (ODP),Pharmaceutical Patents,Patent Litigation,Obviousness,Pfizer,Novelty,Claim Construction,Patent Invalidity
AuthorLei Liu
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT